Avastin® (bevacizumab) Efficacy, Safety, Dosing & Prescribing …
§§§In the Avastin IMbrave150 study, Avastin in combination with atezolizumab in patients with locally advanced unresectable and/or metastatic hepatocellular carcinoma who have not …
How Avastin® (bevacizumab) works for the treatment of …
Learn about Avastin® (bevacizumab) solution for IV infusion, including benefits, risks, possible side effects, patient support, and options for financial help.
Avastin® (bevacizumab) Dosage & Dosing in Approved Cancer …
Learn more about Avastin® (bevacizumab) dosage and dosing schedules for approved indications. See full safety for more information.
Possible Side Effects of Treatment | Metastatic Colorectal ... - avastin
Learn about the possible side effects of mCRC treatment with Avastin® (bevacizumab). See full safety for more information.
Avastin® (bevacizumab) Proposed MOA | MCRC Treatment
Learn more about the proposed Avastin® (bevacizumab) mechanism of action (MOA) for metastatic colorectal cancer (MCRC) treatment. See full safety for more information.
Avastin® (bevacizumab) Dosing | NSCLC Treatment
Learn more about Avastin® (bevacizumab) dosing in 1L metastatic non-squamous non-small cell lung cancer (NSCLC) treatment. See full safety for more information.
Benefits & Risks of Treatment | Metastatic Colorectal Cancer
View benefits and risks of Avastin® (bevacizumab) treatment for metastatic colorectal cancer (mCRC). See full safety for more information.
How is Avastin® (bevacizumab) given for advanced & recurrent …
Learn how Avastin® (bevacizumab) infusion treatments are given for patients with advanced stage III/IV ovarian cancer and recurrent platinum-treated ovarian cancer. See full safety for …
Avastin® (bevacizumab) Dosing | MCRC Treatment
Learn more about Avastin® (bevacizumab) dosing in metastatic colorectal cancer (MCRC) treatment. See full safety for more information.
Benefits & risks of treatment for ovarian cancer - avastin
View benefits and risks of Avastin® (bevacizumab) treatment for advanced stage III/IV ovarian cancer and recurrent platinum-treated ovarian cancer. See full safety for more information.